Cytokinetics, Inc. (CYTK)

63.74 +0.39 (+0.62%) USD  |  NASDAQ  |  Dec 15, 10:47
More

Cytokinetics Average Diluted Shares Outstanding (Quarterly)

Average Diluted Shares Outstanding (Quarterly) Chart

View Average Diluted Shares Outstanding (Quarterly) for CYTK.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Average Diluted Shares Outstanding (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Average Diluted Shares Outstanding (Quarterly) Range, Past 5 Years

View Average Diluted Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Average Diluted Shares Outstanding (Quarterly) Benchmarks

View Average Diluted Shares Outstanding (Quarterly) Benchmarks
Start Trial
Jasper Therapeutics, Inc. Upgrade
Bristol Myers Squibb Co. Upgrade
Lantheus Holdings, Inc. Upgrade
Pfizer Inc. Upgrade
Fortrea Holdings, Inc. Upgrade